Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant predominance
View ORCID ProfileAshish Goyal, View ORCID ProfileDaniel Reeves, View ORCID ProfileJoshua T. Schiffer
doi: https://doi.org/10.1101/2021.03.23.21254185
Ashish Goyal
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center
Daniel Reeves
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center
Joshua T. Schiffer
1Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center
2Department of Medicine, University of Washington, Seattle
3Clinical Research Division, Fred Hutchinson Cancer Research Center

Article usage
Posted March 24, 2021.
Early super-spreader events are a likely determinant of novel SARS-CoV-2 variant predominance
Ashish Goyal, Daniel Reeves, Joshua T. Schiffer
medRxiv 2021.03.23.21254185; doi: https://doi.org/10.1101/2021.03.23.21254185
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (579)
- Anesthesia (140)
- Cardiovascular Medicine (1947)
- Dermatology (185)
- Emergency Medicine (333)
- Epidemiology (11104)
- Gastroenterology (624)
- Genetic and Genomic Medicine (3177)
- Geriatric Medicine (309)
- Health Economics (561)
- Health Informatics (2043)
- Health Policy (863)
- Hematology (310)
- HIV/AIDS (682)
- Medical Education (317)
- Medical Ethics (92)
- Nephrology (334)
- Neurology (2987)
- Nursing (164)
- Nutrition (464)
- Oncology (1553)
- Ophthalmology (478)
- Orthopedics (185)
- Otolaryngology (266)
- Pain Medicine (202)
- Palliative Medicine (57)
- Pathology (403)
- Pediatrics (913)
- Primary Care Research (355)
- Public and Global Health (5592)
- Radiology and Imaging (1095)
- Respiratory Medicine (761)
- Rheumatology (339)
- Sports Medicine (289)
- Surgery (343)
- Toxicology (48)
- Transplantation (159)
- Urology (132)